TEVA stock

Teva Pharmaceutical Industries (TEVA) valuation · P/E 91, rev $17.26B

Teva Pharmaceutical Industries (TEVA) P/E 91, rev $17.26B.

Valuation multiples
MetricValue
P/E91
Market cap$45.77B
Revenue$17.26B
P/S2.7
These valuation metrics as JSON? API free 100/day

TEVA valuation FAQ

What is TEVA's P/E ratio?

Teva Pharmaceutical Industries (TEVA) trailing P/E is 91 on the latest cached fundamentals snapshot.

What is TEVA's market cap?

Teva Pharmaceutical Industries (TEVA) market cap is $45.77B on the latest cached fundamentals snapshot.

What is TEVA's latest revenue?

Latest cached Teva Pharmaceutical Industries (TEVA) revenue was $17.26B. Statements: https://lician.com/financials/teva

What is TEVA's price-to-sales ratio?

Teva Pharmaceutical Industries (TEVA) price-to-sales (P/S) is 2.7, cached market cap $45.77B divided by revenue $17.26B.

How many TEVA valuation scalars are listed on this page?

This page lists 4 cached valuation scalars for Teva Pharmaceutical Industries (TEVA): P/E, Market cap, Revenue, and P/S.

Where is TEVA valuation listed?

Cached valuation multiples for Teva Pharmaceutical Industries (TEVA) are listed at https://lician.com/valuation/teva.

Not investment advice. Figures as filed or reported, not a live feed.